Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 63 results.
User Information
Export Records
  1. 1.   Neutral sphingomyelinase 2 is required for HIV-1 maturation
  2. Waheed, Abdul A; Zhu, Yanan; Agostino, Eva; Naing, Lwar; Hikichi, Yuta; Soheilian,Ferri; Yoo, Seung-Wan; Song, Yun; Zhang, Peijun; Slusher, Barbara S; Haughey, Norman J; Freed, Eric O
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Jul 11; 120(28): e2219475120.
  1. 2.   Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound
  2. Yoo, Seung-Wan; Waheed,Abdul; Deme, Pragney; Tohumeken, Sehmus; Rais, Rana; Smith, Matthew D; DeMarino, Catherine; Calabresi, Peter A; Kashanchi, Fatah; Freed,Eric; Slusher, Barbara S; Haughey, Norman J
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Jul 11; 120(28): e2219543120.
  1. 3.   Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis
  2. Kanai,Tapan; Hu, Zongyi; Yang,Renbin; Wu, Weimin; Wang, Ziqiu; Ma, Christopher D; Sanchez-Meza, Jaime; Law, Mansun; Houghton, Michael; Law, John Lokman; Logan, Michael; de Val, Natalia; Liang, T Jake
  3. Journal of Virology. 2022, Dec 15; e0178822.
  1. 4.   Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
  2. Pahwa, Roma; Dubhashi, Janhavi; Singh, Anand; Jailwala, Parthav; Lobanov,Alexei; Thomas, Craig J; Ceribelli, Michele; Wilson, Kelli; Ricketts, Christopher J; Vocke, Cathy D; Wells, Catherine; Bottaro, Donald P; Linehan, W Marston; Neckers, Len; Srinivasan, Ramaprasad
  3. Journal of Experimental & Clinical Cancer Research : CR. 2022, Jun 27; 41(1): 208.
  1. 5.   Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
  2. Banach, Bailey B.; Cerutti, Gabriele; Fahad, Ahmed S.; Shen, Chen-Hsiang; De Souza, Matheus Oliveira; Katsamba, Phinikoula S.; Tsybovsky, Yaroslav; Wang, Pengfei; Nair, Manoj S.; Huang, Yaoxing; Francino-Urdaniz, Irene M.; Steiner, Paul J.; Gutierrez-Gonzalez, Matias; Liu, Lihong; Acevedo, Sheila N. Lopez; Nazzari, Alexandra F.; Wolfe, Jacy R.; Luo, Yang; Olia, Adam S.; Teng, I-Ting; Yu, Jian; Zhou, Tongqing; Reddem, Eswar R.; Bimela, Jude; Pan, Xiaoli; Madan, Bharat; Laflin, Amy D.; Nimrania, Rajani; Yuen, Kwok-Yung; Whitehead, Timothy A.; Ho, David D.; Kwong, Peter D.; Shapiro, Lawrence; DeKosky, Brandon J.
  3. Cell Reports. 2021, Oct 5; 37(1):
  1. 6.   SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
  2. Olia, Adam S.; Tsybovsky,Yaroslav; Chen, Steven J.; Liu, Cuiping; Nazzari, Alexandra F.; Ou, Li; Wang, Lingshu; Kong, Wing-Pui; Leung, Kwan; Liu, Tracy; Stephens,Tyler; Teng, I-Ting; Wang, Shuishu; Yang, Eun Sung; Zhang, Baoshan; Zhang, Yi; Zhou, Tongqing; Mascola, John R.; Kwong, Peter D.
  3. The Journal of biological chemistry. 2021, Oct; 297(4):
  1. 7.   SARS-CoV-2: from its discovery to genome structure, transcription, and replication
  2. Castro Brant,Ayslan; Tian, Wei; Majerciak,Vladimir; Yang, Wei; Zheng,Zhi-Ming
  3. Cell & bioscience. 2021, Jul 19; 11(1):
  1. 8.   SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
  2. Huang,Szu-Wei; Wang, Sheng-Fan
  3. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021, Mar 17; 22(6):
  1. 9.   Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
  2. Trougakos, Ioannis P.; Stamatelopoulos, Kimon; Terpos, Evangelos; Tsitsilonis, Ourania E.; Aivalioti, Evmorfia; Paraskevis, Dimitrios; Kastritis, Efstathios; Pavlakis,George; Dimopoulos, Meletios A.
  3. Journal of Biomedical Science. 2021, Jan 12; 28(1): 9.
  1. 10.   Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation
  2. Huang, Szu-Wei; Miller, Sorin O.; Yen, Chia-Hung; Wang, Sheng-Fan
  3. Genes. 2020, Dec 24; 12(1):
  1. 11.   The Role of Conformational Dynamics in the Recognition and Regulation of Ubiquitination
  2. Khago, Domarin; Fucci,Ian; Byrd,Robert
  3. Molecules (Basel, Switzerland). 2020, Dec 15; 25(24):
  1. 12.   Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
  2. Zhou, Tongqing; Tsybovsky,Yaroslav; Gorman, Jason; Rapp, Micah; Cerutti, Gabriele; Chuang, Gwo-Yu; Katsamba, Phinikoula S; Sampson, Jared M; Schön, Arne; Bimela, Jude; Boyington, Jeffrey C; Nazzari, Alexandra; Olia, Adam S; Shi, Wei; Sastry, Mallika; Stephens,Tyler; Stuckey, Jonathan; Teng, I-Ting; Wang, Pengfei; Wang, Shuishu; Zhang, Baoshan; Friesner, Richard A; Ho, David D; Mascola, John R; Shapiro, Lawrence; Kwong, Peter D
  3. Cell Host & Microbe. 2020, Dec 9; 28: 867-+.
  1. 13.   Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
  2. Lu, Weiqiang; Yu, Weiwei; He, Jiacheng; Liu, Wenjuan; Yang, Junjie; Lin, Xianhua; Zhang, Yuanjin; Wang, Xin; Jiang, Wenhao; Luo, Jian; Zhang, Qiansen; Yang, Huaiyu; Peng, Shihong; Yi, Zhengfang; Ren, Shancheng; Chen, Jing; Siwko, Stefan; Nussinov,Ruth; Cheng, Feixiong; Zhang, Hankun; Liu, Mingyao
  3. EMBO molecular medicine. 2020, Dec 07; e12798.
  1. 14.   Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
  2. Labo,Nazzarena; Ohnuki, Hidetaka; Tosato, Giovanna
  3. Cells. 2020, JUL; 9(7):
  1. 15.   Crystal structure of the Schizosaccharomyces pombe U7BR E2-binding region in complex with Ubc7
  2. Hann, Zachary S; Metzger,Meredith; Weissman,Allan; Lima, Christopher D
  3. Acta crystallographica. Section F, Structural biology communications. 2019, Aug 01; 75(Pt 8): 552-560.
  1. 16.   Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
  2. Basudhar, Debashree; Glynn, Sharon A; Greer, Madison; Somasundaram, Veena; No, Jae Hong; Scheiblin, David; Garrido, Pablo; Heinz, Will; Ryan, Aideen E; Weiss, Jonathan M; Cheng, Robert Y S; Ridnour, Lisa; Lockett, Stephen; McVicar, Daniel; Ambs, Stefan; Wink, David
  3. Proceedings of the National Academy of Sciences of the United States of America. 2017, Dec 05; 114(49): 13030-13035.
  1. 17.   A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways
  2. Zlotkowski, Katherine; Hewitt, Will; Sinniah, Ranu S; Tropea, Joseph; Needle, Danielle; Lountos, George; Barchi, Joe; Waugh, David; Schneekloth, Jay
  3. SLAS Discovery. 2017, Jul; 22(6): 760-766.
  1. 18.   Conformational Dynamics and Allostery in E2:E3 Interactions Drive Ubiquitination: gp78 and Ube2g2
  2. Chakrabarti, Kalyan S; Li, Jess; Das, Ranabir; Byrd, Robert
  3. Structure (London, England : 1993). 2017, May 2; 25(5): 794-805.
  1. 19.   The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation
  2. von Eyss, B.; Maaskola, J.; Memczak, S.; Mollmann, K.; Schuetz, A.; Loddenkemper, C.; Tanh, M. D.; Otto, A.; Muegge, K.; Heinemann, U.; Rajewsky, N.; Ziebold, U.
  3. Embo Journal. 2012, Feb; 31(4): 972-985.
  1. 20.   Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?
  2. Reizis, B.; Colonna, M.; Trinchieri, G.; Barrat, F.; Gilliet, M.
  3. Nature Reviews Immunology. 2011, Aug; 11(8): 558-U82.
  1. 21.   Variations in Apolipoprotein E Frequency With Age in a Pooled Analysis of a Large Group of Older People
  2. McKay, G. J.; Silvestri, G.; Chakravarthy, U.; Dasari, S.; Fritsche, L. G.; Weber, B. H.; Keilhauer, C. N.; Klein, M. L.; Francis, P. J.; Klaver, C. C.; Vingerling, J. R.; Ho, L.; De Jong, P.; Dean, M.; Sawitzke, J.; Baird, P. N.; Guymer, R. H.; Stambolian, D.; Orlin, A.; Seddon, J. M.; Peter, I.; Wright, A. F.; Hayward, C.; Lotery, A. J.; Ennis, S.; Gorin, M. B.; Weeks, D. E.; Kuo, C. L.; Hingorani, A. D.; Sofat, R.; Cipriani, V.; Swaroop, A.; Othman, M.; Kanda, A.; Chen, W.; Abecasis, G. R.; Yates, J. R.; Webster, A. R.; Moore, A. T.; Seland, J. H.; Rahu, M.; Soubrane, G.; Tomazzoli, L.; Topouzis, F.; Vioque, J.; Young, I. S.; Fletcher, A. E.; Patterson, C. C.
  3. American Journal of Epidemiology. 2011, Jun; 173(12): 1357-1364.
  1. 22.   Regulation of Androgen Receptor Transcriptional Activity and Specificity by RNF6-induced Ubiquitination
  2. Xu, K. X.; Shimelis, H.; Linn, D. E.; Jiang, R. C.; Yang, X.; Sun, F.; Guo, Z. Y.; Chen, H. G.; Li, W.; Chen, H. G.; Kong, X. T.; Melamed, J.; Fang, S. Y.; Xiao, Z.; Veenstra, T. D.; Qiu, Y.
  3. Cancer Cell. 2009 15(4): 270-282.
  1. 23.   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
  2. Ambs, S.; Prueitt, R. L.; Yi, M.; Hudson, R. S.; Howe, T. M.; Petrocca, F.; Wallace, T. A.; Liu, C. G.; Volinia, S.; Calin, G. A.; Yfantis, H. G.; Stephens, R. M.; Croce, C. M.
  3. Cancer Research. 2008 68(15): 6162-6170.
  1. 24.   The mechanism of RNase III action: How Dicer dices
  2. Ji, X. H.
  3. Rna Interference. 2008 320: 99-116.
  1. 25.   Pharmacokinetics, pharmacodynamics and drug metabolism - Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol
  2. Lakhani, N. J.; Sparreboom, A.; Xu, X.; Veenstra, T. D.; Venitz, J.; Dahut, W. L.; Figg, W. D.
  3. Journal of Pharmaceutical Sciences. 2007, Jul; 96(7): 1821-1831.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel